Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex. (April 2020)
- Record Type:
- Journal Article
- Title:
- Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex. (April 2020)
- Main Title:
- Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex
- Authors:
- Wetzstein, Nils
Kohl, Thomas A.
Andres, Sönke
Schultze, Tilman G.
Geil, Ari
Kim, Eunhee
Biciusca, Teodora
Hügel, Christian
Hogardt, Michael
Lehn, Annette
Vehreschild, Maria J.G.T.
Wolf, Timo
Niemann, Stefan
Maurer, Florian P.
Wichelhaus, Thomas A. - Abstract:
- Highlights: Macrolide resistance is a rare event in clinical specimens of M. avium complex. Results of phenotypic drug susceptibility testing have to be considered with care due to impaired stability in rifampicin, doxycyclin and rifabutin. pDST and gDST results should be combined in order to guide antimicrobial therapy in NTM. Changes in susceptibility can be linked to mutation within the same strain, but reinfection is frequent. Abstract: Objective: Phenotypic (Sensititre Myco, pDST) and genotypic drug susceptibility testing (GenoType NTM DR, gDST) in M. avium complex (MAC) have become available as standardized assays, but comparable data is needed. This study aimed to investigate the phenotypic and genotypic drug susceptibility patterns in MAC clinical isolates. Methods: Overall, 98 isolates from 85 patients were included. pDST and gDST were performed on all isolates and results compared regarding specificity and sensitivity using pDST as a reference method. The impact of drug instability on pDST results was studied using a biological assay over 14 days. In addition, the evolution of antimicrobial resistance was investigated in sequential isolates of 13 patients. Results: Macrolide resistance was rare, 1.2% (95% CI 0.7–7.3) of isolates in the base cohort. No aminoglycoside resistances were found, but 14.1% of the studied isolates (95% CI 7.8–23.8) showed intermediate susceptibility. The GenoType NTM DR identified two out of four macrolide-resistant isolates. AntibioticHighlights: Macrolide resistance is a rare event in clinical specimens of M. avium complex. Results of phenotypic drug susceptibility testing have to be considered with care due to impaired stability in rifampicin, doxycyclin and rifabutin. pDST and gDST results should be combined in order to guide antimicrobial therapy in NTM. Changes in susceptibility can be linked to mutation within the same strain, but reinfection is frequent. Abstract: Objective: Phenotypic (Sensititre Myco, pDST) and genotypic drug susceptibility testing (GenoType NTM DR, gDST) in M. avium complex (MAC) have become available as standardized assays, but comparable data is needed. This study aimed to investigate the phenotypic and genotypic drug susceptibility patterns in MAC clinical isolates. Methods: Overall, 98 isolates from 85 patients were included. pDST and gDST were performed on all isolates and results compared regarding specificity and sensitivity using pDST as a reference method. The impact of drug instability on pDST results was studied using a biological assay over 14 days. In addition, the evolution of antimicrobial resistance was investigated in sequential isolates of 13 patients. Results: Macrolide resistance was rare, 1.2% (95% CI 0.7–7.3) of isolates in the base cohort. No aminoglycoside resistances were found, but 14.1% of the studied isolates (95% CI 7.8–23.8) showed intermediate susceptibility. The GenoType NTM DR identified two out of four macrolide-resistant isolates. Antibiotic stability was demonstrated to be poor in rifampicin, rifabutin, and doxycycylin. Conclusions: pDST results in NTM for unstable antibiotics must be interpreted with care. A combination of pDST and gDST will be useful for the guidance of antimicrobial therapy in MAC-disease. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 93(2020)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 93(2020)
- Issue Display:
- Volume 93, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 93
- Issue:
- 2020
- Issue Sort Value:
- 2020-0093-2020-0000
- Page Start:
- 320
- Page End:
- 328
- Publication Date:
- 2020-04
- Subjects:
- AMI amikacin -- CAMHB cation adjusted Mueller-Hinton broth -- CLA clarithromycin -- CIP ciprofloxacin -- CLSI Clinical and Laboratory Standards Institute -- CTAB Cetrimonium bromide -- DOX doxycycline -- ECOFF Epidemiological Cut Off Value -- EMB ethambutol -- ETH ethionamide -- EUCAST European Committee on Antimicrobial Susceptibility Testing -- INH isoniazid -- IQR interquartile range -- gDST genotypic drug susceptibility testing -- pDST phenotypic drug susceptibility testing -- MAbsC Mycobacterium abscessus complex -- MAC Mycobacterium avium complex -- MXF moxifloxacin -- NTM non-tuberculous mycobacteria -- RIF rifampin -- RFB rifabutin -- SNP single nucleotide polymorphism -- SXT trimethoprim/sulfamethoxazole -- WT wild type
NTM -- Non-tuberculous mycobacteria -- M. avium complex -- M. avium -- M. chimaera -- M. Intracellulare -- Drug susceptibility testing -- DST
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2020.02.059 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13420.xml